2025
Zika in Infants and Pregnancy (ZIP) study: results from a prospective international cohort study of prenatal Zika virus infection and adverse fetal and infant outcomes
Lebov J, Nason M, Stolka K, Ximenes R, Mussi-Pinhata M, Moye J, Zorrilla C, Velez Vega C, Cordero J, Scalabrin D, Ko A, Moreira M, Galvão L, Britt W, Marques E, Balmaseda A, Harris E, Arias J, Schultz-Cherry S, Garces A, Krebs N, Ochoa T, Ugarte-Gil C, Fogleman E, Gabriel E, Welton M, Irizarry C, de Moura Negrini S, Coutinho C, de Barros Miranda-Filho D, Montarroyos U, Cordeiro M, Gajewski A, Osorio J, Figueroa L. Zika in Infants and Pregnancy (ZIP) study: results from a prospective international cohort study of prenatal Zika virus infection and adverse fetal and infant outcomes. BMC Pregnancy And Childbirth 2025, 25: 903. PMID: 40885911, PMCID: PMC12399002, DOI: 10.1186/s12884-025-07774-y.Peer-Reviewed Original ResearchConceptsZika virus infectionZIKV exposureCongenital malformationsRelative riskInfant outcomesZika virusComposite endpointPrenatal Zika virus infectionPrimary analysisZika virus exposureSecondary analysisCo-primary analysisWeeks gestationPrimary endpointRNA testingProspective studyProspective cohortPregnant participantsWeeks postpartumPregnancyVirus infectionInfantsAdequate sample sizeInfant deathsPregnant people
2022
Biannual and Quarterly Comparison Analysis of Agglutinating Antibody Kinetics on a Subcohort of Individuals Exposed to Leptospira interrogans in Salvador, Brazil
Cruz J, Nery N, Sacramento G, Victoriano R, Montenegro A, Santana J, Costa F, Ko A, Reis M, Wunder E. Biannual and Quarterly Comparison Analysis of Agglutinating Antibody Kinetics on a Subcohort of Individuals Exposed to Leptospira interrogans in Salvador, Brazil. Frontiers In Medicine 2022, 9: 862378. PMID: 35492362, PMCID: PMC9048256, DOI: 10.3389/fmed.2022.862378.Peer-Reviewed Original ResearchMicroscopic agglutination testAntibody kineticsEndemic areasReinfection eventsSubcohort of individualsBurden of leptospirosisLife-threatening diseaseProspective cohortClinical manifestationsAsymptomatic infectionHumoral responseRisk factorsImmune responseLeptospirosis infectionAgglutination testPaucity of informationSerological surveyLeptospirosisSample collection timeInfectionLeptospira interrogansSubcohortFurther studiesHigh rateDisease
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply